Ladder-Based Pain Management in the Emergency Department
Use a stepwise approach starting with acetaminophen and NSAIDs for mild-moderate pain, escalating to opioids (hydromorphone or fentanyl preferred over morphine) only for severe pain, while steroids and SSRIs have NO routine role in acute ED pain management. 1, 2
The ED Pain Ladder Algorithm
Step 1: Mild to Moderate Pain (NRS 1-6)
- First-line: Acetaminophen (paracetamol) - universally recommended across all age groups 3, 2
- First-line: NSAIDs (ibuprofen 400-600mg every 4-6 hours, naproxen, or celecoxib)
Step 2: Moderate to Severe Pain (NRS 7-10) - IV Route Needed
If IV access available:
- Hydromorphone 0.015 mg/kg IV initially (typically 1-1.5mg), then 1mg after 15 minutes if needed 1
- Preferred over morphine due to faster onset, less dose-stacking risk, and lower toxicity in renal failure 1
- Alternative: Fentanyl 1 mcg/kg IV initially, then ~30mcg every 5 minutes 1
If oral route only:
- Oxycodone-acetaminophen combination - marginally superior to codeine combinations 1
- Continue NSAIDs as part of multimodal approach 2, 4
Step 3: Adjunctive/Alternative Therapies (When Standard Approaches Insufficient)
- Subdissociative ketamine (0.1-0.3 mg/kg IV) - robust evidence for severe pain 5, 4
- Regional anesthesia blocks (PENG block for hip fractures, serratus anterior for rib fractures) 2, 6
- Nitrous oxide - supported evidence base 5
Steroids in the ED: Limited Specific Indications
Steroids are NOT part of routine acute pain management ladders. Their role is condition-specific, not analgesic-ladder based:
When Steroids ARE Indicated:
- Acute gout/pseudogout - anti-inflammatory mechanism
- Acute radiculopathy with nerve root compression - reduce nerve inflammation
- Acute migraine (as abortive therapy, not primary analgesic)
- Acute exacerbations of inflammatory arthritis
Key Point: Steroids address underlying inflammatory pathology, not acute pain per se. They are disease-modifying agents, not analgesics in the traditional ladder sense. None of the ED pain guidelines 1, 2 recommend steroids as part of the analgesic ladder.
SSRIs in the ED: NO Role in Acute Pain Management
SSRIs have absolutely no indication for initiation in the ED for acute pain. 7
Why SSRIs Are Not ED Medications:
- SSRIs are third-line agents for chronic neuropathic pain requiring weeks to months for effect 7
- They belong in outpatient pain management algorithms, not acute ED care
- The algorithm for neuropathic pain places SSRIs after failure of: tricyclic antidepressants, SNRIs (duloxetine/venlafaxine), gabapentinoids, topicals, combination therapy, tramadol, and interventional therapies 7
SNRIs (duloxetine, venlafaxine) are first-line for chronic neuropathic pain in outpatient settings, but still have no role in acute ED presentations 7
Critical ED-Specific Considerations
What You Actually Manage in the ED:
Acute pain = Opioids + NSAIDs + Acetaminophen + Regional blocks + Ketamine
The "reserve" medications you mention (steroids, SSRIs) are not reserve ED analgesics—they simply don't belong in acute ED pain algorithms at all.
Multimodal Approach Means:
- Combine acetaminophen + NSAID for additive effect (different mechanisms) 2, 4
- Add opioid if severe (targets mu-receptors)
- Consider ketamine for opioid-sparing (NMDA antagonist) 5, 4
- Use regional blocks when anatomically appropriate (blocks nociceptive transmission) 2, 6
Common Pitfalls to Avoid:
- Never co-prescribe opioids with benzodiazepines at ED discharge - markedly increases overdose risk 8
- Limit opioid prescriptions to ≤5 days - risk of long-term use increases significantly after 5 days, even with low doses 8
- Avoid morphine - hydromorphone is superior due to faster onset and less dose-stacking 1
- Never use codeine combinations - genetic variability makes them unpredictable and less effective 1
For Chronic Pain Exacerbations:
Do not routinely prescribe opioids for acute exacerbations of chronic non-cancer pain - large systematic review showed no clinically significant benefit over placebo/non-opioid options, but increased adverse events 8. Focus on optimizing non-opioid multimodal therapy and outpatient pain management referral.
Patient-Driven Protocols:
Hydromorphone 1mg + 1mg patient-driven protocol is recommended over physician-driven protocols, especially for patients unable to clearly communicate pain (altered mental status, language barriers) 1